Vivek Mani

Vivek Mani has over a decade of experience leading teams and consulting to clients on regulatory and litigation issues involving competition. His expertise includes collective actions, cartels, and mergers in Europe and the United States. Mr. Mani’s competition experience covers a range of industries, including automobiles, financial institutions, pharmaceuticals, retail, and telecommunications. Lexology Index (formerly Who’s Who Legal) named Mr. Mani a Future Leader among economists in the global competition field and has since recommended hum as a leading competition economist and consulting expert.

Competition in financial markets

Mr. Mani consults to clients on class certification/collective action issues in antitrust matters in U.S. and UK financial markets. He has analyzed price fixing allegations related to asset and benchmark prices, as well as bid-ask spreads for financial instruments across various trading platforms. Mr. Mani has conducted empirical analyses of large proprietary datasets in the context of price fixing allegations.

Pharmaceuticals

Mr. Mani has consulted to pharmaceutical clients on numerous matters, including breach of contract, antitrust, product misrepresentation, and securities and intellectual property. He has addressed issues related to drug development, drug pricing and reimbursement, brand-to-brand competition, generic competition, and damages.

Mr. Mani has testified at an arbitration hearing on damages issues in a life sciences matter.

Merger reviews

Mr. Mani leads merger review teams for the merging parties in the U.S. and Europe. He has assessed horizontal and vertical issues arising in a range of industries, including industrial goods, retail, technology, and telecommunications. Mr. Mani also has experience in sampling and survey design, and in conducting and critiquing surveys as part of Phase II merger inquiries in Europe.

On both sides of the Atlantic, Mr. Mani publishes and speaks extensively on topics related to class certification and collective actions, economic issues in the pharmaceutical industry, and merger analyses.

Mr. Mani has served as a member of Cornerstone Research’s Diversity, Equity, and Inclusion (DEI) Council.